Cargando…

Implications of local failure on overall prognosis in aggressive prostate cancer

Detalles Bibliográficos
Autores principales:	Mula-Hussain, Layth, Roy, Soumyajit, Malone, Shawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354306/ https://www.ncbi.nlm.nih.gov/pubmed/32676383 http://dx.doi.org/10.21037/tau-2020-04

Ejemplares similares

Oncology in Iraq’s Kurdish Region: Navigating Cancer, War, and Displacement
por: Skelton, Mac, et al.
Publicado: (2017)

Treatment of Trigeminal Neuralgia With Stereotactic Radiosurgery Improved Symptoms of Morbihan Syndrome
por: Burgess, Laura, et al.
Publicado: (2021)

Retraction: Treatment of Trigeminal Neuralgia With Stereotactic Radiosurgery Improved Symptoms of Morbihan Syndrome
por: Burgess, Laura, et al.
Publicado: (2022)

CSF Rhinorrhea: A Rare Clinical Presentation of Choroid Plexus Papilloma
por: Mula-Hussain, Layth, et al.
Publicado: (2021)

A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer
por: Burgess, Laura, et al.
Publicado: (2021)

Surgery and dose-escalated radiotherapy for a de novo intracranial squamous cell carcinoma of the cerebellopontine angle
por: Mula-Hussain, Layth, et al.
Publicado: (2021)

Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment
por: Taira, Al V., et al.
Publicado: (2013)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Local staging of prostate cancer with imaging: can hybrid imaging be the solution?
por: Turkbey, Baris
Publicado: (2020)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
por: Julin, B, et al.
Publicado: (2015)

A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer
por: Roumeguère, Thierry, et al.
Publicado: (2017)

Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer
por: Kyprianou, Natasha, et al.
Publicado: (2021)

Rucaparib for metastatic castration-resistant prostate cancer: did TRITON3 deliver a trifecta?
por: Elias, Roy, et al.
Publicado: (2023)

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer
por: Vlaeminck-Guillem, Virginie
Publicado: (2020)

MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
por: Ghamlouche, Fatima, et al.
Publicado: (2023)

Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment
por: Afifi, Nader, et al.
Publicado: (2023)

Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer
por: Roy, Soumyajit, et al.
Publicado: (2023)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Development and validation of a polygenic hazard score for aggressive prostate cancer identification
por: Mohamed, Nihal E., et al.
Publicado: (2019)

The aortic arch management for type A aortic dissection: aggressive but experienced
por: Permanyer, Eduard, et al.
Publicado: (2020)

The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival
por: Sapuppo, Giulia, et al.
Publicado: (2020)

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours
por: Appetecchia, Marialuisa, et al.
Publicado: (2012)

Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers
por: Gulati, Richa, et al.
Publicado: (2022)

The established risk of prostate cancer comorbidity in BRCA1/2 mutation carriers: where is the clinically relevant hotspot for prostate cancer?
por: Matsumoto, Takashi, et al.
Publicado: (2020)

Is there a hierarchy in mental health stigma?
por: Mula, Marco
Publicado: (2022)

Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Aggressive surgical therapy in late stage thymoma: durable long-term control of disease
por: Burt, Bryan M., et al.
Publicado: (2020)

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
por: Xu, Junfeng, et al.
Publicado: (2020)

Is pelvic prophylactic radiotherapy in prostate cancer just right?
por: Taussky, Daniel, et al.
Publicado: (2020)

Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

New models for defining prostate cancer biology and patient prognosis
por: Brundage, James, et al.
Publicado: (2021)

Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis
por: Burton, Anya J., et al.
Publicado: (2021)

Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer
por: Hennigs, Jan K., et al.
Publicado: (2020)

MANAGEMENT OF LOCALLY ADVANCED, AGGRESSIVE PROSTATE CANCER – CASE REPORT
por: Sudarević, Bojan
Publicado: (2019)

Aggressive HIV-1?
por: Berkhout, Ben, et al.
Publicado: (2005)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

Challenges associated with limited‐resources cancer care facility: Bilateral breast myeloid sarcoma as an example
por: Khoshnaw, Najmaddin, et al.
Publicado: (2019)

Tumor human papillomavirus: a potential test for cervical cancer prognosis
por: Le, Tan Minh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9moqjckjba02ag6vrqjvr6nbqs